Search

everythinglearnresearchcommunity

for

Search:↓

Combination therapy improves urinary flow and reduces residual urine, but needs better stent design.

Injecting alpha-melanocyte-stimulating hormone in mice improved skin healing and reduced scarring.

The document concludes that accurate diagnosis and treatment of scalp itch require differentiating between various conditions using a proposed five-step evaluation process.

Early onset baldness in men may indicate a condition similar to PCOS, linked to heart disease, diabetes, and prostate issues.

Dogs could be good models for studying human hair growth and hair loss.

Cell-based therapies show promise for treating Limbal Stem Cell Deficiency but need more research.

Gene therapy, especially using atoh1, shows promise for creating functional sensory hair cells in the inner ear, but dosing and side effects need to be managed for clinical application.

Post-finasteride syndrome causes lasting sexual, neurological, and physical side effects in some people after taking finasteride.

Trichodynia is a painful scalp condition linked to hair loss and inflammation, often with anxiety, affecting more women and needing better treatment options.

Using neurohormones to control keratin can lead to new skin disease treatments.

Nuclear Factor I-C is important for controlling hair growth by affecting the TGF-β1 pathway.

Potassium channel openers show promise for treating heart disease and other conditions, but more research is needed to fully understand their effects and safety.

Lysophosphatidic acid is important for skin health and disease, and could be a target for new skin disorder treatments.

Skin-derived stem cells can become various cell types, including germ cell-like and oocyte-like cells.

Frontal Fibrosing Alopecia's cause is unclear, affects mainly postmenopausal women, and current treatments focus on stopping hair loss rather than regrowth.

Alopecia areata, a type of hair loss, is likely an autoimmune disease with a genetic link, but its exact cause is still unknown.

The current understanding of frontal fibrosing alopecia involves immune, genetic, hormonal factors, and possibly environmental triggers, but more research is needed for effective treatments.

The microenvironment controls adult stem cells' behavior and fate.

Finasteride treats enlarged prostate and baldness, but may cause limited urinary improvement and sex-related side effects.

Taking tamsulosin or finasteride and being older increase the risk of floppy iris during cataract surgery.

Stress can worsen skin conditions and affect mental health, so doctors should include stress management in skin treatment.

COVID-19 might worsen symptoms and progression of benign prostatic hyperplasia, possibly due to inflammation and metabolic disturbances in the prostate gland. More research is needed to confirm this.

Scientists made skin stem cells from other human cells with over 97% efficiency, which could help treat skin conditions.

Alfredo Rebora suggested a new, easier way to classify hair loss in Telogen Effluvium, adding a type possibly related to autoimmune diseases.

Some diseases can improve the outcomes of other diseases, leading to new treatment possibilities.

Some medications for bladder problems can cause memory issues or mood changes, and doctors should monitor these side effects.

PRP shows promise for improving facial wrinkles, skin elasticity, and hair growth, but more research is needed to standardize its use and understand its effects.

Hair diseases can have psychological effects and should be treated with a combination of psychosomatic care, therapy, and medication.

Substance from human umbilical cord blood cells promotes hair growth.

5 alpha-reductase inhibitors can slightly improve symptoms of enlarged prostate but have a high risk of sexual side effects.